- Rogers (NYSE:ROG) recently reported that annual sales have declined by 5.5% for two consecutive years, while rising costs have reduced its operating margin by 7.2 percentage points, pressuring profitability across its engineered materials portfolio.
- This combination of falling revenue and shrinking margins has raised concerns that the company’s products are not fully aligning with current demand in electric vehicles, telecommunications, and other high‑performance applications.
- We’ll now examine how Rogers’ weakening sales and profitability trends may affect the existing investment narrative built around future margin recovery.
Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Rogers Investment Narrative Recap
To own Rogers today, you need to believe its engineered materials remain essential to long term trends in EVs, high frequency electronics, and power applications, and that current earnings pressure is temporary rather than structural. The recent 5.5% annual sales declines and 7.2 percentage point margin compression directly challenge the near term margin recovery story and sharpen the biggest risk right now: that weaker demand and higher costs linger longer than expected.
Against this backdrop, the full year 2025 results are particularly relevant, with net sales slipping to US$810.8 million and a net loss of US$61.8 million. This confirms the profitability strain hinted at by the multi year sales declines, and puts more weight on whether upcoming quarters and the guided Q1 2026 revenue range of US$193 million to US$208 million can show any stabilization in the top line and incremental progress on costs.
Yet investors should also be aware that if end market weakness persists longer than expected, especially in EV power substrates, the path to any meaningful margin recovery could...
Read the full narrative on Rogers (it's free!)
Rogers’ narrative projects $973.0 million revenue and $122.3 million earnings by 2029.
Uncover how Rogers' forecasts yield a $124.33 fair value, a 14% upside to its current price.
Exploring Other Perspectives
Before this setback, the most optimistic analysts expected revenue to reach about US$1.0 billion and earnings around US$318.0 million, highlighting how differently you and others might view Rogers if the China curamik ramp and cost savings plan now look more uncertain in light of two straight years of 5.5 percent sales declines.
Explore 2 other fair value estimates on Rogers - why the stock might be worth less than half the current price!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Rogers research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
- Our free Rogers research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rogers' overall financial health at a glance.
Curious About Other Options?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com